Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20150211Phase 2Active
A Phase 2 trial of Sanhua for injection in brain infarction, sponsored by Tsinghua Yuanxing Pharmaceutical. Started May 2015; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20150211.